From Casetext: Smarter Legal Research

In re Pfizer Inc.

United States District Court, S.D. New York
Oct 21, 2005
No. 04-cv-10071 (RO) (S.D.N.Y. Oct. 21, 2005)

Opinion

No. 04-cv-10071 (RO).

October 21, 2005


MEMORANDUM ORDER


Before this Court at this point are nine ERISA actions against Pfizer, Inc. and certain of its directors and officers, arising from alleged misrepresentations concerning the drugs Celebrex and Bextra. The actions are: 04-cv-10071 and 05-cv-735, 1308, 1920, 2510, 2874, 5719, 5721, and 6327.

These actions are hereby consolidated pursuant to Fed.R.Civ.P. 42(a), as will be any related actions hereafter filed. They shall be captioned In re Pfizer ERISA Litigation, 04-cv-10071. Keller Rohrback L.L.P. is designated as sole Interim Lead Counsel for the Plaintiffs.

So Ordered.


Summaries of

In re Pfizer Inc.

United States District Court, S.D. New York
Oct 21, 2005
No. 04-cv-10071 (RO) (S.D.N.Y. Oct. 21, 2005)
Case details for

In re Pfizer Inc.

Case Details

Full title:IN RE: PFIZER INC. ERISA LITIGATION

Court:United States District Court, S.D. New York

Date published: Oct 21, 2005

Citations

No. 04-cv-10071 (RO) (S.D.N.Y. Oct. 21, 2005)